FeroSul

Quick links to important sections

FeroSul

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of FeroSul

Quick Facts: FeroSul

Property Description
Active Ingredient Ferrous Sulfate (FeSO4)
Form Oral tablet, Oral solution
Pharmacological Class Antianemic Agent
ightarrow Hematinic
General Purpose Essential mineral replacement (Iron)
Origin Synthetic (Prepared compound)

FeroSul: A Definition and Pharmacological Classification

FeroSul is the established trade designation for a pharmaceutical preparation whose active ingredient is the Iron salt, Ferrous Sulfate (FeSO4). It is classified as an Antianemic agent and is functionally defined as a Hematinic, a substance used to support the creation and health of blood components. Various hydrated forms of Ferrous Sulfate are recognized for medicinal use, affirming its standardized status. This formulation is clinically recognized for its role in supporting iron stores, serving as a standard in oral iron therapy. FeroSul is generally available over-the-counter (OTC) and is primarily targeted toward the adult patient group seeking an accessible source of iron.

Composition, Forms, and Essential Mineral Status

The composition of FeroSul is straightforward: it is a Single-ingredient product whose active component is the Ferrous Sulfate compound, which provides the highly absorbable Ferrous ion (Fe^2+). Iron is an Essential mineral replacement because the body cannot produce it and must obtain it externally. Iron is a critical component of hemoglobin, essential for oxygen transport and cellular functioning. The medication is manufactured for the Oral route of administration, available primarily as an Oral tablet and an Oral solution (elixir) form.

General Purpose of this Iron Replacement Therapy

The fundamental purpose of administering FeroSul is to implement controlled Iron replacement therapy. By supplying the necessary Ferrous ion, this Antianemic agent enables the body to sustain erythropoiesis, the fundamental process of red blood cell creation. This class of oral therapy effectively reverses iron deficiency by aiding in the formation of functional red blood cells. A typical use scenario involves a person needing to restore iron levels to assist the body in maintaining its capacity for adequate oxygen supply.

Regulatory References

  1. USP-NF Monograph
  2. NIH Office of Dietary Supplements

What side effects are possible with FeroSul?

Possible Side Effects and Safety Information

The safety profile for FeroSul (Ferrous Sulfate) is formally defined by government regulatory agencies through classifications of adverse reactions, restrictions on use, and specific population-based safety considerations.

Adverse Reaction Classification

The majority of officially documented adverse reactions are concentrated within the Gastrointestinal Disorders system-organ class. These effects are most frequently categorized as Common, often appearing during the initial phase of treatment. Very Common and expected effects include Stool Discoloration (black stools), resulting from unabsorbed iron.

Frequency Category Representative Adverse Reactions
Very Common Stool Discoloration
Common Nausea, Vomiting, Constipation, Abdominal discomfort/pain
Uncommon Rash, Pruritus, Esophageal irritation
Rare Intestinal ulceration, Anaphylaxis

Critical Safety Considerations

Official regulatory documents emphasize the critical risk of accidental poisoning in the pediatric population. Accidental overdose of iron-containing products is listed as a leading cause of fatal poisoning in children under six years of age. Aspiration of the tablet is also documented as a rare but serious risk, which may cause complications in the respiratory system.

Safety Restrictions and Limitations

Ferrous sulfate is officially contraindicated in individuals with existing conditions of iron overload, such as hemochromatosis or hemosiderosis, or in cases of anemias that are not definitively caused by iron deficiency. Caution is also advised for patients with pre-existing gastrointestinal diseases, such as inflammatory bowel disease or peptic ulceration, as these conditions may be exacerbated.

Population-Specific Notes

Specific safety considerations exist for special populations, particularly the pediatric population due to the overdose risk, and older adults where caution is advised due to the potential for increased gastrointestinal complications and swallowing difficulties.

Overdose and Emergency Response

The official regulatory profile for an overdose of Ferrous Sulfate (FeroSul) addresses the risk of Acute Iron Poisoning, which is defined as a severe, multi-stage systemic toxicity. Overdose initially presents with signs of hemorrhagic gastroenteritis, including severe stomach pain, nausea, vomiting (potentially containing blood), and bloody diarrhea.

This acute exposure can rapidly progress to life-threatening manifestations such as shock, hypotension (low blood pressure), severe metabolic acidosis, and damage to major organs, including acute liver failure and coma. Regulatory documents issue a critical warning that accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6 years of age.

Regulators mandate that individuals seek emergency medical attention immediately or contact a Poison Control Center for any suspected overdose. Management procedures are defined as symptomatic and supportive treatment, often requiring hospital monitoring and the administration of the specific chelating agent, Deferoxamine, to manage systemic iron levels. Severe cases necessitate continuous observation due to the risk of cardiovascular collapse.

Therapeutic Uses of FeroSul

What FeroSul Treats: Main Uses and Benefits

FeroSul is generally used to address and resolve Iron Deficiency Anemia (IDA) and states of low body iron, providing common support for addressing this deficiency, which is a condition characterized by periods of systemic imbalance. Oral iron supplements are commonly used to treat or prevent anemia when dietary intake is insufficient. The primary indications include documented iron deficiency anemia, low blood levels of iron, and use in clinical contexts involving recurrent or episodic manifestations of deficiency.

The medication is commonly used to help with the overall symptom burden associated with systemic imbalance. This includes managing symptom clusters such as chronic fatigue, generalized weakness, pale complexion, and symptoms of increased neurological or muscular activity like Restless Legs Syndrome (RLS). It is applied across domains where additional symptomatic support is needed, such as in patients with chronic blood loss or during pregnancy.

“The therapy assists with maintaining functional stability and supports the patient during difficult episodes by easing distress related to low physical energy.”

Quick Fact: Relief for Fatigue and Weakness
Common Use Helps manage fatigue and low endurance linked to anemia.
Primary Benefit Helps maintain a sense of stability during symptomatic periods.
Target Symptoms Pervasive tiredness and lack of physical stamina.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use FeroSul — Official Regulatory Information

The eligibility profile for FeroSul is defined by official regulatory documents, specifying who is permitted to use the medicine and who is strictly prohibited.

Populations for Whom Use is Allowed or Restricted

Category Official Regulatory Status
Standard Use Adults and Adolescents (12 years and over) for iron deficiency.
Pediatric Use Children under 12 years: Use is restricted and requires physician consultation. Children under 6: A Major Safety Warning notes that accidental overdose is a leading cause of fatal poisoning in this age group.
Pregnancy/Lactation Use is acceptable but requires seeking the advice of a health professional before taking the product.
Comorbidity-Based Use is restricted in patients with existing gastrointestinal diseases.

Absolute Contraindications

Use of FeroSul is strictly prohibited in patients with conditions that involve iron overload or non-iron deficiency related anemias:

  • Hemosiderosis or Primary Hemochromatosis (iron overload conditions).
  • Anemias not due to iron deficiency (unless iron deficiency is concurrently present).
  • Severe gastrointestinal conditions including Peptic Ulceration, Ulcerative Colitis, or Regional Enteritis.
  • Patients receiving repeated blood transfusions.

What should I know about interactions with other medicines?

FeroSul Interactions with Other Medicines and Products

This section outlines the formally documented interaction patterns for FeroSul (Ferrous Sulfate), based strictly on government regulatory information.


Prohibited and Restricted Combinations

FeroSul is formally contraindicated with the use of Parenteral Iron Therapy and for patients receiving Repeated Blood Transfusions. These restrictions are in place to prevent severe iron overload.

Interactions Requiring Timing Separation

FeroSul can reduce the absorption of certain co-administered medications, necessitating spaced dosing intervals as mandated by regulatory labels. This applies to:

  • Tetracycline Antibiotics and Quinolone Anti-infective Agents (e.g., Ciprofloxacin).
  • Levothyroxine (Thyroid Hormone).
  • Bisphosphonates, Penicillamine, and Antacids.

Interactions Affecting Absorption

FeroSul's absorption is reduced by several substances and foods documented in official sources:

  • Medicines: Antacids, Cholestyramine, Trientine, and Magnesium Trisilicate.
  • Minerals/Supplements: Calcium Salts and Zinc Salts.
  • Foods/Beverages: Tea, coffee, milk, eggs, and whole-grain cereals may impair oral iron absorption.

Conversely, regulatory information notes that Ascorbic Acid (Vitamin C) increases iron absorption, and Chloramphenicol may enhance the response to iron therapy.

Population-Specific Cautions

A specific caution is noted for the tablet form in elderly patients and those with swallowing difficulties due to the officially documented risk of bronchial necrosis from aspiration.

Mechanism of Action

How FeroSul Works

FeroSul (mathrmFeSO4) functions as an essential mineral replacement, defined by its role as a fundamental substrate provider for critical metabolic and transport systems. The primary action is the direct provision of the essential ferrous ion (mathrmFe^2+) that acts as a cofactor in the final stage of the heme synthesis pathway within the bone marrow. This molecular step enables the effective synthesis of Hemoglobin (Hb), the protein essential for binding and carrying oxygen. This mechanism of erythropoiesis contributes to the capacity for oxygen-carrying capacity in the circulation.

Beyond oxygen transport, the mathrmFe^2+ ion is incorporated into iron-dependent enzymes, such as the cytochromes found in the mitochondrial electron transport chain. This action is necessary for oxidative phosphorylation—the process responsible for generating cellular energy (mathrmATP). Simultaneously, absorbed iron is incorporated into storage proteins like Ferritin and muscle oxygen proteins like Myoglobin, contributing to localized metabolic processes. The mechanism is subject to homeostatic control by Hepcidin, which constrains absorption via the Ferroportin exporter, imposing a physiological constraint that results in a delayed onset of the systemic effect.

Dosage and Administration Information

Administration Guidelines

FeroSul, which contains the active ingredient ferrous sulfate, is administered via the oral route (by mouth). There are specific guidelines for dosing, timing, and product handling established for standardized use.

Administration Scope Detail
Route of Administration Oral
Dosing Schedule (Adults, Therapeutic) Typically 100 mg to 200 mg of elemental iron per day, often taken in divided doses (two to three times daily).
Dosing Schedule (Adults, Prophylaxis) One tablet providing approximately 65 mg of elemental iron once daily (QD).
Timing in relation to meals Best absorbed on an empty stomach, but may be taken with or after food to mitigate gastrointestinal discomfort. Avoid taking with coffee, tea, milk, or eggs.
Age-group administration rules Dosing for children is determined based on weight and blood results, and often utilizes liquid forms. For individuals 12 years and over, adult dosing may apply.

Special Procedural Conditions

Instructions for use specify that tablets must be swallowed whole with water. Tablets should not be sucked, chewed, or kept in the mouth due to the risk of mucosal ulceration and tooth discoloration. If using the liquid form, it may be mixed with water or fruit juice and should be consumed using a straw to prevent temporary tooth staining.

Inter-Dose Timing and Duration

Therapy with FeroSul is typically a long-term regimen intended to correct iron deficiency and replenish the body’s iron stores. Treatment is usually continued for three to six months after anemia correction is achieved, but the total duration should generally not exceed six months. Administration must be separated from certain oral medications (e.g., tetracyclines, levothyroxine) by at least two hours to prevent absorption interference. If a dose is missed, the standard procedure is to skip the missed dose if the next scheduled dose is near, and not to take a double dose.

Recent Clinical Evidence

FeroSul: Recent Clinical Evidence

Clinical evidence for ferrous sulfate (FeroSul), the standard oral iron salt, focuses primarily on its use for iron deficiency anemia (IDA). Research consistently evaluates its effectiveness in replenishing iron stores and normalizing hemoglobin levels.

Studies show that a rise in hemoglobin levels is typically observed within three to four weeks of beginning therapy. Achieving full replenishment of iron stores, measured by serum ferritin levels, generally requires continued therapy for at least three months after hemoglobin levels have normalized.

Tolerability and Absorption Studies

Recent research has centered on managing the common side effects associated with oral iron. Systematic reviews and meta-analyses confirm that ferrous sulfate supplementation is associated with a significantly increased risk of gastrointestinal (GI) side effects compared to both placebo and intravenous iron alternatives. These effects often include constipation, nausea, and abdominal discomfort.

Research Focus Key Findings
Dosing Frequency Studies have evaluated alternate-day dosing regimens, suggesting that this approach may improve iron absorption and enhance patient tolerability compared to daily dosing.
Co-administration Research has explored the interaction of ferrous sulfate with other medications, such as methotrexate (a common arthritis drug), finding no significant interference with its absorption.

Clinical trials continue to investigate novel formulations and administration schedules to optimize the balance between effective iron absorption and patient compliance, which is often limited by GI side effects.

Frequently Asked Questions (FAQ)

Common questions about FeroSul (FAQ)


Q: How long until I feel the full effects of FeroSul?

Based on clinical data, most patients may start to notice an improvement within the first week of taking FeroSul. However, the full therapeutic benefit may take 4 to 6 weeks. The full effect depends on consistent adherence to the prescribed regimen.

The official product information typically includes a warning against abrupt discontinuation, as this may be associated with withdrawal symptoms. Concerns about the drug's effectiveness or any aspect of treatment should be discussed with a healthcare professional.


Q: Can I take FeroSul with my daily multivitamin and other supplements?

The prescribing information for FeroSul does not typically list common multivitamins as a known interaction that requires complete avoidance. However, St. John's Wort is a supplement that is typically cautioned against in the regulatory information due to a potential for an increased risk of specific side effects.

All supplements, herbal products, and over-the-counter medications should be reviewed with a healthcare provider to assess any potential for drug interactions.


Q: What happens if I miss a dose of FeroSul?

Information for patients on missing a dose of FeroSul often provides the following guidelines: Standard recommendations often suggest taking the dose as soon as the patient remembers, unless it is close to the time for the next scheduled dose.

If the time is near the next scheduled dose, patients are typically advised to skip the missed dose and resume their normal schedule. Taking two doses at once to compensate for a missed dose is generally not recommended, as this may increase the risk of experiencing adverse effects.

How should FeroSul be stored and disposed of?

FeroSul (Ferrous Sulfate) must be stored and disposed of based strictly on regulatory requirements to ensure product stability and safety.

Detail Official Regulatory Requirement
Storage Temperature Controlled room temperature: 20 to 25 C (68 to 77 F); excursions permitted to 30 C (86 F).
Protection Must be protected from light and excessive moisture and must not be frozen.
Container Rule Store in the original container and keep the container tightly closed.
Child Protection Must be kept out of reach of children due to the high risk of fatal poisoning from accidental overdose. Child-resistant closures are required.
Disposal Dispose of according to local regulations. The product is not on the FDA flush list and should not be discarded down a sink or toilet. Unused medicine should be disposed of via drug take-back programs or secure household waste procedures.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of FeroSul found in:

A-Z Index: